Actively Recruiting
Enhancing Care in Patients After Coronary Artery Bypass Graft Surgery: OptiCABG Study
Led by Chinese Academy of Medical Sciences, Fuwai Hospital · Updated on 2024-07-05
40000
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
This research evaluates data from patients who underwent coronary artery bypass grafting (CABG) at the National Center for Cardiovascular Disease, Fuwai Hospital, between January 2013 and June 2023. It includes reviewing medical history, head CT scans, and postoperative outcomes such as 30-day mortality, arrhythmia, cerebrovascular disease, and intracerebral hemorrhage. The study uses case-control and retrospective cohort methods to investigate risk factors linked to early postoperative complications and their connection with postoperative care, aiming to build predictive models for compound complications. The study involves collecting and analyzing retrospective data from patients who had CABG surgery, focusing on early postoperative complications like atrial fibrillation and major adverse cardiac events (MACE) occurring around the second postoperative day. It does not involve interventions or treatments but rather observes and reviews existing patient records to identify independent risk factors and relationships affecting postoperative outcomes. Participants are patients who underwent CABG within the specified timeframe and meet inclusion criteria. Researchers assess outcomes such as 30-day mortality and postoperative complications using medical records and imaging results. The study tracks these outcomes to understand risks and improve postoperative management. No new treatments or procedures are administered, and participation involves data review only.
CONDITIONS
Brief Title
Enhancing Care Study in Patients After CABG
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients who underwent coronary artery bypass grafting (CABG) surgery enrolled from January 2013 to June 2023
You will not qualify if you...
- Patients discharged within 72 hours of admission
- Patients diagnosed with atrial fibrillation at admission
- Patients who had emergency CABG surgery
- Patients who underwent other concurrent surgical treatments
- Patients with repeat hospital admissions
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Around the second postoperative day
Participants undergo coronary artery bypass graft (CABG) surgery and are observed during the immediate post-operative period.
1 to 2 visits around surgery
Duration - 30 days
Participants are monitored for recovery and outcomes such as mortality and major adverse cardiac events during the 30 days after surgery.
Follow-up visits as scheduled within 30 days
Trial Site Locations
Total: 1 location
1
Structral Heart Disease Center, Fuwai Hospital
Beijing, Beijing Municipality, China
Actively Recruiting
Research Team
Z
Ziping Li, MD
Y
Yiming Yan, MD
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here